Fierce Healthcare
NOVEMBER 5, 2021
Nearly 32,000 Kaiser Permanente workers set to strike Nov. 15. Tens of thousands more mulling their own demonstrations. dmuoio. Fri, 11/05/2021 - 10:58.
pharmaphorum
NOVEMBER 3, 2021
A real-world study of digital therapeutic (DTx) for opioid use disorder has found that patient show used it had 46% fewer hospital stays than a control group, saving more than $2,700 over a nine-month period. The study of Pear Therapeutics’ reSET-O found that the total cost of hospital and clinician costs were $11,141 among 64 patients who were prescribed the DTx but didn’t use it, but fell to $8,733 among active users of the 12-week course.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
NOVEMBER 1, 2021
The cloud software firmâs Digital Clinical Trials Survey Report reveals that the industry is adapting to challenges caused by COVID-19 and other factors.
Pharma Marketing Network
NOVEMBER 4, 2021
Jim Lefevere is an award-winning highly-influential agile intrapreneur with over 20 years of expertise in the consumer goods, startups, medical device, and healthcare industries. Jim has enjoyed a very diverse and successful career with progressive growth in leadership, global marketing, digital marketing, and strategy development. Jim is a visionary intrapreneur at a global scale as a social media pioneer, digital health scholar, and agile leader.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
NOVEMBER 3, 2021
Notable nabs $100M to automate administrative tasks in healthcare, boosts valuation to $600M. rtorrence. Wed, 11/03/2021 - 11:07.
pharmaphorum
NOVEMBER 5, 2021
An oral antiviral drug developed by Pfizer has been shown to dramatically cut the risk of hospitalisation or death from COVID-19 when given in the early stages of infection. The phase 3 trial found that Paxlovid – which combines new protease inhibitor PF-07321332 with already-approved HIV drug ritonavir – reduced the risk of hospitalisation or death by 89% when given to newly-diagnosed adults who were at risk of developing severe COVID-19 in the EPIC-HR trial.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Lifewell Rx Pharmacy
NOVEMBER 1, 2021
Medications are beneficial for the recovery of patients. These have been specially formulated to help improve the health condition of a person. For every ailment, there is a specific medication. This is why it is of utmost importance for patients to find a retail pharmacy that they can rely on. A community pharmacy in Kentucky won’t only provide medications and medical supplies, but it can also help assist patients with their other medical needs.
Fierce Healthcare
NOVEMBER 3, 2021
Former Livongo exec launches women's health startup that uses data for personalized care. hlandi. Wed, 11/03/2021 - 11:24.
pharmaphorum
NOVEMBER 1, 2021
Novartis has claimed FDA approval for one of its ‘wild card’ drugs – Scemblix – a first-in-class STAMP inhibitor for patients with previously-treated chronic myeloid leukaemia (CML). Scemblix (asciminib) was one of a clutch of high risk, high reward drug candidates for a range of diseases that Novartis chief executive Vas Narasimhan said last year were flying under-the-radar of industry watchers, but could potentially develop into blockbusters.
Outsourcing Pharma
NOVEMBER 1, 2021
The trial will evaluate a weekly regimen of islatravir and lnecapavir in HIV patients who are virologically suppressed while on antiretroviral therapies.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Birth Control Pharmacist
NOVEMBER 2, 2021
The Society of Family Planning (SFP) annual meeting was held virtually on October 1 st and 2 nd this year with well over one thousand attendees. For those who are not familiar with SFP, it is a community of like-minded people including clinicians, academics, residents, fellows, and students who share the same interest for family planning. SFP values diversity, equity, and the science behind abortion and contraception for everyone.
Fierce Healthcare
OCTOBER 31, 2021
Medicare drops end-stage renal disease payment rule that aims to close health equity gaps. hlandi. Sun, 10/31/2021 - 16:09.
pharmaphorum
NOVEMBER 5, 2021
Novartis has chalked up another successful trial for its targeted factor B inhibitor iptacopan, an orally-active drug trying to challenge antibody-based therapies for diseases associated with the complement pathway. A phase 2 trial of iptacopan in patients with the rare kidney disease C3 glomerulopathy (C3G) – which causes progressive kidney failure and has no approved treatments – showed reductions in kidney damage with the drug that Novartis said were “clinically important.” C3G of
Outsourcing Pharma
NOVEMBER 2, 2021
The global pharmaceutical industry event is returning to the real world November 9-11 this year, with online content for professionals opting not to travel.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmig
NOVEMBER 1, 2021
As you know, we had high hopes we could meet face-to-face, but sadly it's not meant to be. However, fear not, the conference is still going ahead and will be a virtual event. The post Annual November Conference 2021 appeared first on Pharmig.
Fierce Healthcare
NOVEMBER 4, 2021
CMS: Healthcare workers must receive their first COVID vaccine by Dec. 5 to continue Medicare, Medicaid participation. dmuoio. Thu, 11/04/2021 - 09:51.
pharmaphorum
NOVEMBER 4, 2021
After more than 20 years, Novartis has finally decided to sell its substantial share in fellow Swiss pharma group Roche for $20.7 billion, a decent return on its original $5 billion investment. The agreement will see Novartis lose its one-third voting share stake in Roche, after agreeing to sell 53.3 million Roche bearer shares at their average price over 20 days prior to 2 November, when the deal was agreed.
Outsourcing Pharma
NOVEMBER 2, 2021
An expert from the specialty chemicals firm (and CPhI Worldwide speaker) explains trends and developments in excipients and how they drive advancements.
Fuld
NOVEMBER 1, 2021
Background + Challenge. A competitor of a global technology consultancy was experiencing a number of operational challenges which were impacting the satisfactory execution of large-scale contracts in Europe, several with departments of national governments. This was leading to negative articles in the national and business press, the erosion of customer confidence and trust, and, in some cases, the loss of large—scale contracts.
Fierce Healthcare
NOVEMBER 2, 2021
CMS physician fee schedule rule cuts payments, expands telehealth reimbursement past 2023. rking. Tue, 11/02/2021 - 17:16.
pharmaphorum
NOVEMBER 4, 2021
Routine vaccination with human papillomavirus vaccines have resulted in an 87% reduction in cervical cancer cases in England, and could even see the need for smear tests phased out in future, according to a new study. The jabs with have been offered by the NHS to girls between the ages of 12 and 13 since 2008, with more than 10 million doses administered since then, and from September 2019 was also offered to boys in the same age group.
Outsourcing Pharma
NOVEMBER 3, 2021
CPhI Worldwide will see Gerresheimer showcase its latest developments in primary packaging, drug delivery systems for newly developed biologics along with medical and diagnostic products.
Pharma Tutor
OCTOBER 30, 2021
TRADITIONAL USES OF ADHATODA VASICA, ARADUSO. About Authors. Manish Kumar 1 , Vikram S. Chauhan 2 , Raaz K Maheshwari 3 *. 1 Department of Zoology, Narain College, Shikohabad, UP. 2 Department of Botany, Bangur Govt PG College, Pali, Rajasthan. 3 Department of Chemistry, SBRM Govt PG College, Nagaur, Rajasthan. *gcacs60@gmail.com. admin. Sat, 10/30/2021 - 17:10.
Fierce Healthcare
NOVEMBER 5, 2021
Kaiser Permanente's hospital-at-home push prioritizes savings over high-quality care, nurses union says. dmuoio. Fri, 11/05/2021 - 15:49.
pharmaphorum
NOVEMBER 4, 2021
Two kidney transplant patients who received a stem cell therapy developed by Talaris Therapeutics were able to come off all immunosuppressant drugs within a year, without any evidence of graft rejection. The first findings from Talaris’ phase 3 trial of the cell therapy – called FCR001 – suggest it may be possible to eliminate the need entirely for patients to take what may be dozens of tablets daily after organ transplants , according to the US biotech.
Outsourcing Pharma
NOVEMBER 4, 2021
This monthâs announcements of programs, names, appointments, hires, and other happenings includes items from Emmes, Science 37, Cerner and other companies.
Fuld
NOVEMBER 2, 2021
The post Content marketing Case Study – Creating a competitive intelligence battlecard appeared first on Fuld + Co.
Fierce Healthcare
NOVEMBER 2, 2021
Hundreds of organizations urge governors to extend telehealth licensure flexibilities. rtorrence. Tue, 11/02/2021 - 14:32.
pharmaphorum
NOVEMBER 2, 2021
Rocketing sales of COVID-19 vaccine Comirnaty have allowed Pfizer to raise its full-year forecasts for the shot once again to a whopping $36 billion, more than double its predictions just a few months ago. Fuelled by extensions to vaccination programmes to include children and booster shots, the BioNTech-partnered jab made nearly $13 billion in the third quarter, around $2 billion more than analyst consensus forecasts.
Outsourcing Pharma
NOVEMBER 3, 2021
The CPhI Worldwide exhibitor will show Syloid XDP, a silica carrier designed to convert liquid, waxy, or oily active ingredients into free-flowing powders.
Med Ed 101
NOVEMBER 3, 2021
A 77 year old male has a history of atrial fibrillation which had been well controlled on metoprolol 50 mg BID. He presents today reporting an increase in pounding in his chest and indeed, vital signs reveal that his heart rate is at 125 BPM. You are questioned if any of his medications could possibly […]. The post Drug-Induced Tachycardia Case Scenario appeared first on Med Ed 101.
Fierce Healthcare
NOVEMBER 3, 2021
AMIA 2021: Understanding how technology impacts patients and providers. agliadkovskaya. Wed, 11/03/2021 - 12:10.
pharmaphorum
NOVEMBER 3, 2021
The EMA has started its review of AstraZeneca and Daiichi Sankyo’s Enhertu for a second indication, as a second-line treatment for HER2-positive gastric cancer. If approved the new indication for antibody-drug conjugate Enhertu (trastuzumab deruxtecan) will add to its first EU approval in advanced HER2-positive breast cancer after two or more HER2-targeted therapies.
Outsourcing Pharma
NOVEMBER 2, 2021
During CPhI Worldwide, leaders from two organizations will outline how CM is taking off, potential benefits, and how to clear common obstacles to adoption.
Expert insights. Personalized for you.
145 
Let's personalize your content